A citation-based method for searching scientific literature

Alex Mas Monteys, Shauna A Ebanks, Megan S Keiser, Beverly L Davidson. Mol Ther 2017
Times Cited: 140



Seung Woo Cho, Sojung Kim, Yongsub Kim, Jiyeon Kweon, Heon Seok Kim, Sangsu Bae, Jin-Soo Kim. Genome Res 2014
Times Cited: 813




List of shared articles



Times cited

CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases.
Garima Sharma, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang-Soo Lee, Chiranjib Chakraborty. Mol Ther 2021
10

Novel CRISPR-Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives.
Sweta Nidhi, Uttpal Anand, Patrik Oleksak, Pooja Tripathi, Jonathan A Lal, George Thomas, Kamil Kuca, Vijay Tripathi. Int J Mol Sci 2021
4

Chromatin Alterations in Neurological Disorders and Strategies of (Epi)Genome Rescue.
Marcin Janowski, Małgorzata Milewska, Peyman Zare, Aleksandra Pękowska. Pharmaceuticals (Basel) 2021
0

The Off-Targets of Clustered Regularly Interspaced Short Palindromic Repeats Gene Editing.
Manuel M Vicente, Miguel Chaves-Ferreira, João M P Jorge, João T Proença, Vasco M Barreto. Front Cell Dev Biol 2021
0

Gene Therapy for Huntington's Disease Using Targeted Endonucleases.
Magdalena Dabrowska, Marta Olejniczak. Methods Mol Biol 2020
7

A glance at genome editing with CRISPR-Cas9 technology.
Antara Barman, Bornali Deb, Supriyo Chakraborty. Curr Genet 2020
13

CRISPR Diagnosis and Therapeutics with Single Base Pair Precision.
Seung Hwan Lee, Young-Ho Park, Yeung Bae Jin, Sun-Uk Kim, Junho K Hur. Trends Mol Med 2020
12

Mutation-Independent Allele-Specific Editing by CRISPR-Cas9, a Novel Approach to Treat Autosomal Dominant Disease.
Kathleen A Christie, Louise J Robertson, Caroline Conway, Kevin Blighe, Larry A DeDionisio, Connie Chao-Shern, Amanda M Kowalczyk, John Marshall, Doug Turnbull, M Andrew Nesbit,[...]. Mol Ther 2020
1

CRISPR-Cas9 system: A genome-editing tool with endless possibilities.
Swati Tyagi, Robin Kumar, Aparup Das, So Youn Won, Pratyoosh Shukla. J Biotechnol 2020
9

CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases.
Ansar Karimian, Negar Gorjizadeh, Forough Alemi, Zatollah Asemi, Khalil Azizian, Jafar Soleimanpour, Faezeh Malakouti, Niloufar Targhazeh, Maryam Majidinia, Bahman Yousefi. Life Sci 2020
9

Delivery Approaches for Therapeutic Genome Editing and Challenges.
Ilayda Ates, Tanner Rathbone, Callie Stuart, P Hudson Bridges, Renee N Cottle. Genes (Basel) 2020
13

Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders.
Sudhanshu P Raikwar, Nidhi S Kikkeri, Ragha Sakuru, Daniyal Saeed, Haris Zahoor, Keerthivaas Premkumar, Shireen Mentor, Ramasamy Thangavel, Iuliia Dubova, Mohammad Ejaz Ahmed,[...]. J Neuroimmune Pharmacol 2019
9

CRISPR-engineered genome editing for the next generation neurological disease modeling.
Weijun Feng, Hai-Kun Liu, Daisuke Kawauchi. Prog Neuropsychopharmacol Biol Psychiatry 2018
6